Coffee Made in Workplace Machines Is Worse for Your Cardiovascular Health Than Home-Brewing Methods, Research Shows
A new study — published in the scientific journal Nutrition, Metabolism and Cardiovascular Diseases — analyzed samples from 14 coffee machines in four different workplaces in Sweden to determine whether office coffee raises cholesterol compared to brewing coffee at home.
'Intake of insufficiently filtered coffee during working hours could be an overlooked factor for cardiovascular health due to its effect on plasma cholesterol concentrations,' researchers concluded.
This means coffee from your office machines might contain more cholesterol-raising compounds, similar to the samples in this study.
'Based on the concentrations of cafestol and kahweol in investigated machine coffees, thoroughly filtered coffee seems like the preferable choice for cardiovascular health,' researchers continued. 'Accordingly, filtered coffee should be preferred, also in workplace settings.'
Related: Man Says His Sister Is 'Quite Upset' at Him for Drinking Coffee in Front of Her Young Son Who 'Likes to Copy Me'
Researchers studied samples from three types of office machines: brewing machines, liquid-model machines and instant machines.
'Brewing machines produce coffee from whole or ground beans in approximately [10 to 30 seconds], as the hot water mixes with the coffee and passes a metal filter,' the study noted. 'Liquid-models can provide a cup within seconds and do not use a filter, but instead mix a liquid coffee concentrate with hot water. Instant machines mixes use instant, freeze-dried coffee with hot water.'
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
The researchers compared those workplace methods to other commonly used methods to brew and paper-filter coffee at home: drip-brewed coffee, percolator, French press/cafetière and boiled coffee.
Comparing the machines to these more thoroughly filtered methods, the researchers recommended that 'replacing three cups of brewing machine coffee with paper-filtered coffee five days per week was estimated to reduce LDL cholesterol' (a.k.a. bad cholesterol) over time.
Related: Majority of U.S. Teens Are Not Drinking, Smoking or Using Marijuana, Study Finds
Other studies have touted the benefits of coffee — in moderation — to cardiovascular, cognitive, metabolic and neurological health.
Dr. Donald Hensrud wrote for the Mayo Clinic that 'drinking coffee may be linked to a lower risk of: Parkinson's disease, type 2 diabetes and Alzheimer's disease among some groups of people; metabolic syndrome and chronic kidney disease; liver cancer and liver disease, including cirrhosis; and gallstones and kidney stones.'
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
18 minutes ago
- Associated Press
Biomed Industries Presents Four Breakthrough Studies on Alzheimer's, Rett Syndrome, and Obesity Therapies at AAIC 2025
Biomed Industries, Inc. Presents Four Pivotal Studies at AAIC 2025 Highlighting Breakthrough Therapies for Alzheimer's, Rett Syndrome, and Obesity 'NA-831 is the only drug to date that has halted Alzheimer's disease progression. Combining it with existing drugs like Donanemab could optimize therapeutic efficacy and reduce serious side effects.'— Dr. Lloyd L. Tran, CEO of Biomed SAN JOSE, CA, UNITED STATES, August 4, 2025 / / -- Biomed Industries, Inc., a leading biopharmaceutical innovator developing transformative therapies for neurological and metabolic diseases, today announced the presentation of four major scientific papers at the Alzheimer's Association International Conference (AAIC), held July 27–31, 2025, in Toronto, Canada. The presentations featured Biomed's next-generation oral therapies for Alzheimer's disease, Rett syndrome, and obesity, with a focus on novel combination strategies designed to enhance safety, efficacy, and accessibility. Featured AAIC 2025 Presentations: 1. The End of the Amyloid Era? Evidence for a Paradigm Shift in the Quest to Treat Alzheimer's Disease 2. A Phase 3 Clinical Protocol of NA-831 Combined with Donanemab in Early Alzheimer's Disease: A Placebo-Controlled, Double-Blind Study 3. Associations Between Alzheimer's Disease and Rett Syndrome: Clinical Trials of NA-831 and NA-921 4. Neuro-Metabolic Link Between Alzheimer's Disease and Obesity: Clinical Evaluation of NA-831 and NA-931 1. PRESENTATION: The End of the Amyloid Era? A Paradigm Shift in Alzheimer's Research For over three decades, the 'amyloid hypothesis' has dominated Alzheimer's disease (AD) research, asserting that amyloid-β accumulation is a primary driver of neurodegeneration. Biomed's comprehensive analysis of Phase 3 trial data from seven anti-amyloid drugs — including aducanumab, lecanemab, donanemab, gantenerumab, bapineuzumab, crenezumab, and solanezumab — challenges this paradigm. Across all trials, both treatment and placebo groups exhibited similar cognitive decline, as measured by CDR-SB and ADAS-Cog. The average differences between treatment and placebo arms were minor and not clinically significant (CDR-SB: -0.25; ADAS-Cog: -0.79). Slope comparisons further revealed near-identical rates of decline between groups. 'Our analysis of Phase 3 clinical trial data for seven anti-amyloid drugs, including FDA-approved Aducanumab, Lecanemab, and Donanemab, indicates that none could halt disease progression in a clinically meaningful way — and all carried serious safety concerns,' said Dr. Zung Tran, VP of Biostatistics and AI at Biomed. 2. PRESENTATION: Phase 3 Clinical Protocol of NA-831 Combined with Donanemab NA-831, Biomed's lead oral candidate, is a first-in-class therapy that promotes neuroprotection, neurogenesis, and memory enhancement. Phase 2 trials demonstrated its disease-modifying potential with a favorable safety profile compared to traditional anti-amyloid drugs. In this upcoming Phase 3 study, NA-831 will be evaluated in combination with Donanemab, a recently FDA-approved monoclonal antibody, to explore synergistic effects. The goal is to lower Donanemab dosing, thereby reducing risks such as cerebral edema and microbleeds, while enhancing cognitive outcomes. 'NA-831 is the only drug to date that has halted disease progression in Phase 2 trials,' said Dr. Lloyd Tran, CEO of Biomed Industries. 'Combining it with existing drugs like Donanemab could optimize therapeutic efficacy and reduce serious side effects.' 3. PRESENTATION: Alzheimer's and Rett Syndrome: Shared Mechanisms and Dual Therapeutic Potential Biomed also presented findings on NA-921, a structural analog of NA-831 developed for Rett syndrome, a rare X-linked neurodevelopmental disorder. NA-921 modulates MeCP2 expression, targeting the disorder's core epigenetic dysfunction. A double-blind, placebo-controlled Phase 2/3 trial ( ID: NCT06849973) demonstrated promising results: Clinical Global Impression–Improvement (CGI-I) at week 12: NA-921: 3.60 | Placebo: 3.83 | P = 0.0020 | Effect size = 0.42 NA-921 was well tolerated, with a significantly improved safety profile compared to trofinetide: - Diarrhea: Trofinetide 82%, NA-921 24%, Placebo 19% - Vomiting: Trofinetide 29%, NA-921 9%, Placebo 11% - Fever: Trofinetide 9%, NA-921 5%, Placebo 4% These findings underscore a possible biological link between Alzheimer's disease and Rett syndrome, opening new cross-indication opportunities for NA-831 and NA-921. 4. PRESENTATION: Neuro-Metabolic Connections: NA-831 and NA-931 in Alzheimer's and Obesity Biomed's data also revealed compelling evidence of a neuro-metabolic bridge between Alzheimer's disease, diabetes, and obesity. In addition to NA-831's CNS benefits, Biomed is advancing NA-931, an oral quadruple receptor agonist (IGF-1, GLP-1, GIP, and glucagon) designed to treat obesity. In a 13-week Multiple Ascending Dose (MAD) study: - Mean body weight reduction: Up to 13.8% at 150 mg daily, 12.4% greater than placebo - ≥12% weight loss achieved by 72% of NA-931-treated patients vs. 2% in placebo group NA-931 demonstrated a strong safety profile, with mild and transient GI-related adverse events, and no observed muscle loss. 'Our pipeline shows how targeting interconnected pathways across the CNS and metabolic systems can unlock significant clinical potential,' said Michael Willis, VP of Business Development. 'With six active programs across Alzheimer's, ALS, Rett syndrome, stroke, obesity, and MASH, we are building a diversified platform to accelerate innovation and value creation.' ABOUT BIOMED INDUSTRIES, INC. Biomed Industries, Inc. is a pioneering biopharmaceutical company committed to developing novel therapeutics that address unmet medical needs. Its innovative research platform has produced treatments for conditions including Alzheimer's disease, ALS, Traumatic Brain Injury, Major Depressive Disorder, Diabetes, Obesity, MASH, Stroke, and rare diseases such as Huntington Disease and Rett Syndrome. (Website: ) Michael Willis Biomed Industries, Inc. email us here Visit us on social media: LinkedIn X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
39 minutes ago
- Yahoo
‘It's just PR': Skittles, Hershey and Nestle are removing artificial colors
The Trump administration declared victory after Kraft Heinz, Skittles and General Mills made splashy announcements to remove artificial colors — even taking credit for Coca-Cola's plan to replace high-fructose corn syrup with US cane sugar in a new version this fall. 'President Trump delivers on MAHA (Make America Healthy Again) push,' the White House said last month, touting the companies' changes to 'confront the chronic health crisis plaguing Americans.' But nutritionists and public health researchers don't buy the hype. So far, companies have only made performative changes, they say, many of which were long in the works due to consumer demand for natural ingredients. Meanwhile, the administration's funding cuts for health care, food stamps, research and public health programs run contrary to its goal of making Americans healthier. 'These are cosmetic changes with no health impact. They just allow the MAHA people to say they had a victory,' said Dr. Barry Popkin, a professor of nutrition at the University of North Carolina. 'It's just PR.' Health advocates do credit Robert F. Kennedy Jr., the Health and Human Services Department secretary, and his MAHA movement for bringing attention to unhealthy foods, chronic disease and major companies' influence on the food system in America. But researchers say Kennedy's focus on synthetic dyes misses the larger problem of the prevalence of cheap, convenient foods loaded with salt, sugar and fat. Ice cream is still ice cream and soda is still soda, even without artificial flavors, Popkin said. A spokesperson for the HHS said Kennedy is 'dismantling the status quo that fueled a nationwide chronic disease epidemic' and 'eliminating bureaucracy and restoring integrity to federal health programs.' 'HHS is confronting the root causes of chronic illness that previous administrations were too timid to address,' the spokesperson added. But for Kennedy and the administration to make a substantive impact on Americans' diets, researchers say they will have to implement policies that tightly regulate ultraprocessed foods. Ultraprocessed foods account for up to 70% of the US food supply, and include many popular brands of chips, cookies, candy, ice cream and pre-made meals. Studies have frequently linked them to obesity, cancer, diabetes, heart disease and other health disorders. Kennedy has called the easy availability of these foods a 'crisis,' and oversaw the White House's Make America Healthy Again Commission report released in May that identifies ultraprocessed foods as a key contributor to a national rise in chronic illnesses — particularly among children. The agency has yet to enact any significant measures to cut down on ultraprocessed foods. 'Right now, they're not going after the real food culprit,' Popkin said. 'If Kennedy does anything significant on ultraprocessed foods, it will be hugely important for health.' 'Aura of health foods' Synthetic dyes, made from petroleum, are often used to make food and beverages brightly colored and appealing to customers, especially children. But they have potential negative effects on animal and human health, including possible increased risk of cancer and neurobehavioral issues in some children. In January, the US Food and Drug Administration banned red dye No. 3 in food, beverages and ingested drugs. Kennedy has been pressuring food companies to voluntarily remove all food dyes from their products. But many have been moving away from synthetic dyes for years due to pressure from consumers, health advocates and bans or restrictions in states like California, Virginia and West Virginia. For example, both Kraft Heinz and General Mills — which the administration recently celebrated for pledging to remove synthetic colors — have already removed the additives from most of their products. '(As) much as I love the idea of getting rid of artificial colors, doing so is a nutritionally meaningless way of giving compliant junk foods the aura of health foods,' said Dr. Marion Nestle, an emeritus professor of nutrition and food studies at New York University. Roughly 64% of consumers now actively look for snacks perceived as 'good for them,' a figure that has increased sharply in recent years, according to market research firm Circana. Yogurt, cheeses and foods and drinks with protein have proliferated due to their nutritional appeal. This is also not the first time companies have made voluntary pledges to remove artificial dyes from their products. But many have backtracked on their commitments. 'We hope industry will voluntarily improve the food supply this time around,' said Aviva Musicus, the science director at the Center for Science in the Public Interest, a nonprofit consumer advocacy group. 'There has to be a plan to hold industry accountable for when they inevitably don't cooperate. I haven't seen that for this administration.' The Consumer Brands Association, a trade group representing major food, beverage and household product companies, did not respond directly to this criticism. But the group pointed to an April statement that said the industry has 'always prioritized transparency and it will continue to lead the way to ensure consumers have the information they want and need to make informed purchasing decisions.' And slapping foods with a broad definition of ultraprocessed may result in 'demonizing safe, shelf-ready foods' that will limit consumers' access to nutritious foods, the group said. Cuts to Medicaid and SNAP While HHS focuses on food additives, many of the Trump administration's other policies weaken government efforts to improve the food supply and Americans' health, critics say. Trump's sweeping tax and spending cuts package is expected to leave 10 million more people without health insurance in 2034, according to a Congressional Budget Office estimate. More than 22 million families will lose some or all of their Supplemental Nutrition Assistance Program (SNAP) benefits, according to the Urban Institute. The law eliminated funding for programs that offer cooking classes and nutrition education for SNAP recipients, and the Agriculture Department cut two pandemic-era programs that help schools and food banks buy from local farmers. 'While MAHA leadership celebrates hollow wins, we've seen the federal government cut SNAP benefits for millions of Americans, rip millions from their health insurance coverage (and) slash programs to help farmers bring local foods into schools,' Musicus said. The administration is not just cutting health care and food benefits — it also slashed billions in research funding and fired thousands of employees at the National Institutes of Health, Centers for Disease Control and other agencies. The top nutrition researcher at NIH, who focused on studying ultraprocessed foods, left the agency, citing censorship under Kennedy. (HHS previously denied the claims.) These research cuts and layoffs may make it impossible to enact stricter rules or investigate the food industry, said Dr. Jerold Mande, an adjunct professor at the Harvard School of Public Health and a senior policy official in the Obama and Clinton administrations. 'They've also lost tens of thousands of people across government to do these investigations,' he said. 'Incomplete' grade At the same time, some health experts are hopeful Kennedy will seize on political momentum to make major policy changes to improve Americans' diets. 'I do give RFK Jr. a lot of credit for making chronic disease caused by our food, principally obesity, a political priority,' Mande said. 'I give them an incomplete in terms of what they're going to do about it.' In August, the MAHA Commission will release the second report on its strategy for improving childhood chronic obesity. Advocates will be looking to see if the report signals the administration may try to mandate front-of-package warning labels or crack down on marketing junk food to children. The report may also provide clues to whether the administration will create dietary guidelines with recommendations for limits to ultraprocessed foods. These would be major moves, but they may clash with the administration's deregulatory agenda. 'People are right to question what the lasting policy change is going to be,' Mande said, noting that removing artificial colors matters only if Kennedy is 'laying the groundwork to take on ultraprocessed food broadly.' CNN's Kristen Rogers contributed to this article. Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
How many Tropical Smoothie Cafe locations are in Georgia?
Georgia is known for its comfort foods from fried delicacies to barbecued delights. But the Peach State also has some things to eat on the lighter side. A locally-based chain with locations all over the nation was recently ranked as one of USA Today's 10Best restaurants for quick, healthy food. Editors and experts nominated their favorites, then those were voted on by readers. The 10 crowned boast quick, healthy food offering customizable, health-conscious menus, efficient service, and affordable options. What is Georgia's best restaurant for quick, healthy food? The only Georgia restaurant to make the list is the Tropical Smoothie Cafe chain. While it was founded in Florida, its headquarters has since relocated to Atlanta. Here's what the 10Best writers had to say about it: "Tropical Smoothie Cafe offers a massive array of beverages that are perfectly designed with your health in mind, with drinks like the Detox Island Green and Chia Banana Boost that provide guests with a double punch of flavor and nutrition that's perfect for starting off your day with a bang. Add to that a selection of health-conscious bowls, salads, and wraps, and you're set." What are Tropical Smoothie Cafe's best menu items? "Eat This, Not That!" is a popular healthy eating website. In September, they ranked the healthiest foods and drinks from Tropical Smoothie. Best bowl: Mixed Berry Greek Yogurt Best food: Spinach Feta and Pesto Wrap Best smoothie: Detox Island Green They also ranked the unhealthiest things you can order from Tropical Smoothie: Mocha Madness Buffalo Chicken Wrap Pomegranate Plunge Chia Oatmeal Pudding Bowl How many Tropical Smoothie Cafe locations are in Georgia? There are 58 Tropical Smoothie Cafes in Georgia, according to ScrapeHero. The full list of Peach State places can be found at What are the best restaurants for quick, healthy food in US? Jason's Deli QDOBA Mexican Eats El Pollo Loco Taziki's Mediterranean Cafe Chipotle Mexican Grill Cava Panera Bread Chick-fil-A Tropical Smoothie Cafe Arby's Miguel Legoas is a Deep South Connect Team Reporter for Gannett/USA Today. Find him on Instagram @miguelegoas and email at mlegoas@ This article originally appeared on Savannah Morning News: USA Today ranks Georgia smoothie chain in 10Best for quick, healthy food Solve the daily Crossword
